Advance Research in Imaging-Guided Cancer Therapy
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 58
Special Issue Editors
Interests: nuclear medicine; PET imaging; neuroendocrine tumors; PRRT; neurodegenerative diseases
Interests: nuclear medicine; PET imaging; neuroendocrine tumors; PRRT; paraganglioma; pheochromocytoma; thyroid medullary carcinoma; infection
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We welcome you to contribute to this Special Issue dedicated to "Advanced Research in Imaging-Guided Cancer Therapy". Imaging-guided cancer therapy represents a paradigm shift in oncology, enabling the precise visualization of tumors and their microenvironment, thus empowering clinicians to tailor treatment strategies with unprecedented accuracy. From early detection and diagnosis to treatment planning, monitoring, and response assessment, imaging techniques play a pivotal role at every stage of the cancer care continuum. Moreover, by integrating imaging modalities with therapeutic interventions, such as targeted drug delivery, radiotherapy, and minimally invasive procedures, researchers are ushering in a new era of personalized, precision medicine.
This Special Issue aims to showcase the latest advancements in imaging-guided cancer therapy, highlighting groundbreaking research and technological innovations that promise to shape the future of oncology. Through a collection of original research articles and reviews, we aim to provide a comprehensive overview of the current state-of-the-art in this rapidly evolving field. Topics of interest include, but are not limited to, the following:
- Novel imaging techniques for cancer detection, characterization, and staging;
- Image-guided interventions for minimally invasive cancer treatment;
- Theranostic agents and multimodal imaging approaches;
- Artificial intelligence and machine learning in imaging analysis and interpretation;
- Image-based biomarkers for treatment response prediction and prognosis;
- Translation of imaging-guided therapies from bench to bedside;
- Challenges and opportunities in clinical implementation and validation;
- Ethical, regulatory, and socioeconomic considerations in imaging-guided cancer care.
We invite researchers to contribute their original research and insights to this Special Issue, fostering interdisciplinary collaboration and knowledge exchange in the pursuit of improved outcomes for cancer patients.
We look forward to receiving your contributions.
Dr. Valentina Berti
Prof. Dr. Alessio Imperiale
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- imaging-guided therapies
- theranostic
- cancer
- PET imaging
- nuclear medicine
- nuclear oncology
- precision medicine
